Inactive Instrument
Irwin Naturals Inc. Stock Canadian Securities Exchange
Stocks
IWIN
CA46414Q1054
Pharmaceuticals
OTC Markets Traded| Market Cap | 483K 418K 390K 358K 673K 45.97M 684K 4.58M 1.8M 23.04M 1.81M 1.77M 76.17M | P/E 2021 |
105x | P/E 2022 | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.17M 16.97M 15.57M 29.28M 2B 29.75M 199M 78.16M 1B 78.9M 77.17M 3.31B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.31x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 01/01/1994 |
Mark Green
DFI | Director of Finance/CFO | - | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Other | Chief Executive Officer | 0 | - | ||
| 16/08/21 | Marche | Chief Executive Officer | 18,240 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 708K | |
| -1.04% | +2.59% | +83.91% | +159.55% | 1,062B | |
| -0.22% | +0.08% | +49.57% | +48.22% | 619B | |
| +0.48% | -2.33% | +23.25% | +63.04% | 431B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 358B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 293B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 247B | |
| +0.55% | +5.63% | +42.90% | +60.85% | 219B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 200B | |
| +2.11% | +2.67% | +21.23% | +65.72% | 162B | |
| Average | +0.83% | -1.90% | +34.57% | +49.05% | 399.14B | |
| Weighted average by Cap. | +0.27% | -0.83% | +47.87% | +75.06% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 86.8M 81.05M 74.36M 140M 9.55B 142M 951M 373M 4.79B 377M 369M 15.82B | 89.47M 77.39M 72.27M 66.3M 125M 8.52B 127M 848M 333M 4.27B 336M 329M 14.11B |
| Net income | 8.62M 7.45M 6.96M 6.38M 12.01M 820M 12.2M 81.65M 32.05M 411M 32.35M 31.64M 1.36B | -3.99M -3.45M -3.22M -2.96M -5.56M -380M -5.65M -37.83M -14.85M -190M -14.99M -14.66M -630M |
| Net Debt | 9.35M 8.09M 7.56M 6.93M 13.04M 890M 13.24M 88.64M 34.79M 446M 35.12M 34.35M 1.47B | 20.53M 17.76M 16.58M 15.21M 28.61M 1.95B 29.07M 195M 76.36M 979M 77.09M 75.4M 3.24B |
Employees
-
Sector
Pharmaceuticals
